Risk Factors for Repeat Infection and Mortality After Extraction of Infected Cardiovascular Implantable Electronic Devices
CIED - Lead Management
This study sought to investigate the factors associated with repeat infection following lead extraction procedures.
Although lead extraction is an essential therapy for patients with cardiovascular implantable electronic device (CIED) infection, repeat infection still occurs in some patients.
The authors reviewed data for consecutive patients who underwent extraction of infected CIEDs from August 2003 to May 2019. Repeat infection was defined as infective endocarditis, sepsis with no alternative focus, or pocket infection after extraction of infected CIEDs.
Extraction of infected CIEDs was performed in 496 patients. The most commonly implicated pathogen was Staphylococcus aureus (n = 188). In 449 patients (90.5%), all leads were completely extracted using only transvenous techniques. Thirty-three patients (6.7%) underwent surgical lead extraction, and 14 (2.8%) had retained leads or lead components. After a median follow-up of 352 [40 to 1,255] days after CIED extraction, 144 patients (29.0%) died. Repeat infection occurred in 47 patients (9.5%) with the median time from the extraction to repeat infection of 103 [45 to 214] days. In multivariable analysis, presence of a left ventricular assist device, younger age at extraction, and S. aureus infection were independent predictors of repeat infection. Additionally, chronic kidney disease, congestive heart failure, presence of septic emboli, S. aureus infection, and occurrence of major complications were independent predictors of increased mortality.
Patients with S. aureus infection have a high risk of repeat infection and poor prognosis after CIED extraction. Repeat infection is also predicted by younger age and the presence of a left ventricular assist device, whereas mortality was predicted by congestive heart failure, chronic kidney disease, and septic emboli.
1. "2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction". Heart Rhythm 2017;14:e503-e551.
2. "Trends of cardiovascular implantable electronic device infection in 3 decades: a population-based study". J Am Coll Cardiol EP 2019;5:1071-1080.
3. "Predictors of long-term survival free from relapses after extraction of infected CIED". Europace 2018;20:1018-1027.
4. "Mortality and cost associated with cardiovascular implantable electronic device infections". Arch Intern Med 2011;171:1821-1828.
5. "Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association". Circulation 2010;121:458-477.
6. "2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)". Eur Heart J 2015;36:3075-3128.
7. "Lead-related infective endocarditis: factors influencing early and long-term survival in patients undergoing transvenous lead extraction". Heart Rhythm 2017;14:43-49.
8. "Mayo Cardiovascular Infections Study Group. Predictors of mortality in patients with cardiovascular implantable electronic device infections". Am J Cardiol 2013;111:874-879.
9. "Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study". Heart 2012;98:724-731.
10. "Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival". Europace 2014;16:1490-1495.
11. "Can implantable cardiac electronic device infections be defined as 'early' or 'late' based on the cause of infection?". J Med Microbiol 2013;62:1215-1219.
12. "Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey". Clin Infect Dis 2012;54:1230-1239.
13. "Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens". Heart 2005;91:932-937.
14. "Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species". Am J Cardiol 2012;110:1143-1149.
15. "Reimplantation and repeat infection after cardiac-implantable electronic device infections: experience from the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) database". Circ Arrhythm Electrophysiol 2017;10:e004822.
16. "Prevention and treatment of Staphylococcus aureus biofilms". Expert Rev Anti Ther 2015;13:1499-1516.
17. "Early surgery versus conventional treatment for infective endocarditis". N Engl J Med 2012;366:2466-2473.
18. "Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia - nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the US". Clin Infect Dis 2019;69:2112-2118.
19. "Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users". Antimicrob Agents Chemother 1990;34:1227-1231.
20. "Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections". J Cardiovasc Electrophysiol 2014;25:1199-1205.
21. "Cardiovascular implantable electronic device infections in left ventricular assist device recipients". Pacing Clin Electrophysiol 2014;37:225-230.
22. "Prospective, multicenter study of ventricular assist device infections". Circulation 2013;127:691-702.
23. "Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management". Circulation 1997;95:2098-2107.
24. "Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction". Am Heart J 2003;146:339-344.
25. "Clinical characteristics of septic pulmonary embolism in adults: a systematic review". Respir Med 2014;108:1-8.
26. "Remnant pacemaker lead tips after lead extractions in pacemaker infections". Korean Circ J 2016;46:569-573.
27. "Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study". Pacing Clin Electrophysiol 2019;42:1105-1110.
28. "Coronary stent infections: a case report and literature review". Tex Heart Inst J 2012;39:884-889.
29. "Comparison of leadless pacing and temporary externalized pacing following cardiac implanted device extraction". J Innov Card Rhythm Manag 2019;10:3930-3936.